Business in Brief: Experimental ebola treatment approved for use in Congo
Gilead Science’s experimental ebola treatment approved for use in Congo ■ Bank regulator extends benefits to encourage downsizing ■ BiondVax Pharmaceuticals CEO admits to insider trading, to pay 70,000 shekel fine
Read More
No comments